»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð : À¯Çü, ¿ëµµ, ÄÄÆ÷³ÍÆ®, ¼Ö·ç¼Ç - Áö¿ªÀû Àü¸Á, °æÀï Àü·«, ºÎ¹® ¿¹Ãø(-2033³â)
Life Science Software Market Size- By Type, By Application, By Component, By Solutions - Regional Outlook, Competitive Strategies and Segment Forecast to 2033
»óǰÄÚµå : 1441469
¸®¼­Ä¡»ç : SPER Market Research Pvt. Ltd.
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 234 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,878,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù
US $ 5,650 £Ü 7,815,000
PDF (Group License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù.
US $ 7,450 £Ü 10,304,000
PDF (Company License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù.


Çѱ۸ñÂ÷

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß 13.11%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2033³â¿¡´Â 647¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº COVID-19ÀÇ À¯Çà¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ Ä¡·á¹ý ¹× ¹é½ÅÀÇ °³¹ßÀÌ ±Þ¼±¹«°¡ µÇ°í ÀÖÀ¸¹Ç·Î Drug Discovery, À¯ÀüüÇÐ, ÀÓ»ó½ÃÇèÀ» Áö¿øÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ´ë¸é ȸÀǰ¡ ±ÝÁöµÇ¾ú±â ¶§¹®¿¡ ¿ø°Ý±Ù¹« ¹× Çù¾÷ ÅøÀÌ ÇÊ¿äÇϸç, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû ¹× ¿Â¶óÀÎ Çù¾÷ ÅøÀÇ µµÀÔÀÌ ½Ã±ÞÇØÁö°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½ÃÀå º¯¼ö¿Í Àü¸Á

Á¦6Àå °æÀï ±¸µµ

Á¦7Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

Á¦8Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°

Á¦9Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦10Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼Ö·ç¼Çº°

Á¦11Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¿¹Ãø

Á¦12Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

Á¦13Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°

Á¦14Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦15Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼Ö·ç¼Çº°

Á¦16Àå ¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°

Á¦17Àå ±â¾÷ °³¿ä

Á¦18Àå ¾à¾î ¸®½ºÆ®

Á¦19Àå Âü°í ¸µÅ©

Á¦20Àå °á·Ð

Á¦21Àå Á¶»ç ¹üÀ§

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Life Science Software Market Introduction and Overview

According to SPER market research, 'Life Science Software Market - By Type, By Application, By Component, By Solution- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Life Science Software Market is predicted to reach USD 64.71 billion by 2033 with a CAGR of 13.11%.

Life science software includes a range of tools for standardizing workflow and document management in the biopharmaceutical, medical technology, generics, and clinical care sectors. These programs allow businesses to capture, store, and preserve data using images and text. There are various types of life science software available, such as drug identification and validation, laboratory management, clinical trial management, and medical device development.

Furthermore, the global market for life science software has been significantly affected by the COVID-19 pandemic. Because of the urgency of developing treatments and vaccines for the virus, there is an increased demand for software solutions that aid in drug discovery, genomics, and clinical trials. The ban on in-person meetings necessitated remote work and collaboration tools, hastening the adoption of cloud-based platforms and online collaboration tools.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Application, By Component, By Solution

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Allscripts Healthcare LLC, Cerner Corporation , Cognizant, CPSI , Elinext , EPIC Systems Corporation, INFOR, Jag products LLC ,Meta, Oracle

Global Life Science Software Market Segmentation:

By Type: Based on the Type, Global Life Science Software Market is segmented as; Descriptive, Predictive and Prescriptive.

By Application: Based on the Application, Global Life Science Software Market is segmented as; Compliance, Marketing, R & D, Pharmacovigilance and SCM.

By Component: Based on the Component, Global Life Science Software Market is segmented as; Software and Services.

By Solutions: Based on the Solutions, Global Life Science Software Market is segmented as; Cloud- Based and On- Premises.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Market variable and outlook

6. Competitive Landscape

7. Global Life Science Software Market, By Type (USD Million)

8. Global Life Science Software Market, By Application (USD Million)

9. Global Life Science Software Market, By Component (USD Million)

10. Global Life Science Software Market, By Solution (USD Million)

11. Global Life Science Software Market Forecast, 2020-2033 (USD Million)

12. Global Life Science Software Market, By Type, 2020-2033 (USD Million)

13. Global Life Science Software Market, By Application, 2020-2033 (USD Million)

14. Global Life Science Software Market, By Component, 2020-2033 (USD Million)

15. Global Life Science Software Market, By Solution, 2020-2033 (USD Million)

16. Global Life Science Software Market, By Region, 2020-2033 (USD Million)

17. Company Profile

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â